9 METERS BIOPHARMA INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NMTRQ and buy or sell other stocks, ETFs, and their options commission-free!About NMTRQ
9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs.
CEOBethany L. Sensenig, MBA
CEOBethany L. Sensenig, MBA
Employees10
Employees10
HeadquartersRaleigh, North Carolina
HeadquartersRaleigh, North Carolina
Founded2012
Founded2012
Employees10
Employees10
NMTRQ Key Statistics
Market cap1.45K
Market cap1.45K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume4.58K
Average volume4.58K
High today$0.0001
High today$0.0001
Low today$0.0001
Low today$0.0001
Open price$0.0001
Open price$0.0001
Volume4.11K
Volume4.11K
52 Week high$0.0003
52 Week high$0.0003
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
9 METERS BIOPHARMA INC(NMTRQ) stock is priced at $0.00, giving the company a market capitalization of 1.45K.
During the trading session on 2025-12-15, 9 METERS BIOPHARMA INC(NMTRQ) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading volume for 9 METERS BIOPHARMA INC(NMTRQ) stock has reached 4.11K, versus its average volume of 4.58K.
Over the past 52 weeks, 9 METERS BIOPHARMA INC(NMTRQ) stock has traded between a high of $0.00 and a low of $0.00.
Over the past 52 weeks, 9 METERS BIOPHARMA INC(NMTRQ) stock has traded between a high of $0.00 and a low of $0.00.
People also own
Based on the portfolios of people who own NMTRQ. This list is generated using Robinhood data, and it’s not a recommendation.